Select your localized edition:

Close ×

More Ways to Connect

Discover one of our 28 local entrepreneurial communities »

Be the first to know as we launch in new countries and markets around the globe.

Interested in bringing MIT Technology Review to your local market?

MIT Technology ReviewMIT Technology Review - logo


Unsupported browser: Your browser does not meet modern web standards. See how it scores »

{ action.text }

Artificial retinas are already in human clinical trials at the University of Southern California, where they have helped blind patients distinguish walls from doorways and even watch soccer games, albeit as blurs of motion. But approximating normal vision–and possibly enabling people to read–will require devices that can deliver electrical current with much greater control and precision. A new chip densely packed with electrodes, developed by scientists at the University of California, Santa Cruz (UCSC), is the first step in that direction.

Currently being used in research, the chip can stimulate and record from individual cells in retinal samples. The technology will provide insight into how the retina codes information and how to mimic that coding–lessons that will be crucial in developing the next generation of retinal implants. Further down the road, some version of the technology might be used to send visual information down the optic nerve.

“The retina is a very sophisticated visual-information-processing device,” says Alan Litke, a physicist at UCSC who is applying his expertise to neurobiology. “To have a human patient someday approach normal visual functioning, such as reading, you need to have a very accurate level of control.”

The retina is a thin layer of cells at the back of the eye; photoreceptor cells in the retina detect light and send signals to the retinal ganglion cells, which then transmit the signals to the brain through the optic nerve. In macular degeneration and retinitis pigmentosa, two leading causes of blindness, photoreceptor cells are damaged, but the remaining retinal ganglion cells are left largely intact. Artificial retinas, which rely on an external camera to capture visual information, consist of a processor that translates that information into an electrical code intelligible to the nerve cells of the eye, and a chip dotted with tiny electrodes that transmit the electrical signals to the retinal ganglion cells.

Litke and his collaborators modeled their chip after the silicon microchip detectors that line supercolliders to capture signs of elusive, high-energy, subatomic particles, such as the Higgs boson. Using common integrated-circuit fabrication techniques, the researchers custom-built more than 500 electrodes and amplifiers onto a small glass strip. “There are other commercial, multi-electrode recording systems available, but the team at UCSC has really pushed the technology forward by coming up with a system with the capability to record many more neural responses,” says Matt McMahon, a scientist at Second Sight, the company based in Sylmar, CA, that’s developing the retinal prostheses used in the USC study. Second Sight is using Litke’s device to inform the design of future prostheses. The company’s first-generation device had 16 electrodes, the second-generation device currently in human trials has 60, and a 200-electrode version is under development. (See “Next-Generation Retinal Implant.”)

11 comments. Share your thoughts »

Credit: Alan Litke

Tagged: Biomedicine, implant, chip, vision, retina, implantable chip

Reprints and Permissions | Send feedback to the editor

From the Archives


Introducing MIT Technology Review Insider.

Already a Magazine subscriber?

You're automatically an Insider. It's easy to activate or upgrade your account.

Activate Your Account

Become an Insider

It's the new way to subscribe. Get even more of the tech news, research, and discoveries you crave.

Sign Up

Learn More

Find out why MIT Technology Review Insider is for you and explore your options.

Show Me